Sakar Healthcare Quarterly Results
Sakar Healthcare quarterly results. In Sept 2026, Sakar Healthcare (SAKAR) reported revenue ₹88 Cr and net profit ₹11 Cr — revenue +49.2% YoY. For annual financials, live price and key ratios, visit Sakar Healthcare share price screener.
SAKAR Quarterly Results — Revenue, Profit & EPS Highlights
Sakar Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. View SAKAR annual price range for the annual high/low range and current price position.
- Revenue of ₹88 Cr in Sept 2026 (+23.9% vs Mar 2026, +49.2% vs Sept 2025)
- Net Profit of ₹11 Cr in Sept 2026 (+0.0% vs Mar 2026, +120.0% vs Sept 2025)
- EBITDA of ₹25 Cr in Sept 2026 (-3.8% vs Mar 2026)
- Operating Margin of 28.0% in Sept 2026 (-9.0pp vs Mar 2026)
- Earnings Per Share of ₹5.08 in Sept 2026 (+2.4% vs Mar 2026)
Sakar Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
SAKAR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2026 | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2025 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 88 | 71 | 75 | 59 | 50 | 23.9% | 49.2% |
| Net Profit (₹ Cr) | 11 | 11 | 10 | 5 | 6 | - | - |
| EBITDA (₹ Cr) | 25 | 26 | 23 | 13 | 16 | - | - |
| EPS (₹) | 5.08 | 4.96 | 4.62 | 2.03 | 2.66 | - | - |
| Operating Margin (%) | 28.0% | 37.0% | 29.0% | 20.0% | 31.0% | - | - |
SAKAR Share Price Trend — 1-Year Movement Across Quarterly Results
Sakar Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore Sakar Healthcare stock price data download to track price trends across different timeframes.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
SAKAR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Sakar Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2026 |
₹451,074.97 Cr | 1900.0 | 16,617 | 1,995 | +10.6% | - | 12.0% | 228.9 |
|
Divis Laboratories
Sept 2026 |
₹294,139.19 Cr | 11178.0 | 3,770 | 1,127 | +26.3% | - | 29.9% | 263.1 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4611.0 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 400.6 |
|
Apollo Hospitals
Sept 2026 |
₹126,832.45 Cr | 8738.0 | 7,673 | 660 | +15.2% | - | 8.6% | 199.4 |
|
Laurus Labs
Sept 2026 |
₹125,946.78 Cr | 2306.0 | 2,219 | 436 | +21.7% | - | 19.6% | 282.3 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores